TRPC6 and ischemia: The predominant constituent of green tea, (-)-epigallocatechin-3-gallate (EGCG), introduced immediately after ischemia, demonstrates neuroprotection by decreasing calpain activity and activating TRPC6/CREB via the mitogen-activated protein kinase (MEK)/extracellular pathway [111].